JAGX
$0.28
Jaguar Health
$.00
(1.72%)
JAGX
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  $0.00
Revenue:  $1.87 Mil
Friday
Aug 26
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when JAGX reports earnings?
Beat
Meet
Miss

Where is JAGX's stock price going from here?
Up
Flat
Down
Stock chart of JAGX
Analysts
Summary of analysts' recommendations for JAGX
Score
Grade
Pivots
Resistance
$0.32
$0.30
$0.29

$0.28

Support
$0.27
$0.26
$0.25
Tweet
Growth
Description
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.